Role of cyclooxygenase‐2 and inducible nitric oxide synthase in pancreatic cancer
- 7 August 2002
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 17 (8), 914-921
- https://doi.org/10.1046/j.1440-1746.2002.02829.x
Abstract
Background and Aim: Recently, it has been recognized that both cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS) produce important endogenous factors of human tumor progression. However, the clinicopathological and biological significance of the expression of COX‐2 and iNOS in pancreatic cancer remains unclear. The objective of this study is to find the possible roles and clinical significance of COX‐2 and iNOS expression in pancreatic cancer. Methods: Seventy‐two pancreatic adenocarcinoma tissue specimens were obtained through surgical resection. We investigated the immunohistochemical expression of COX‐2 and iNOS in respect to variable clinicopathological characteristics, proliferation activity (by Ki‐67 expression), apoptosis (by terminal deoxyribonucleotidyl transferase‐mediated dUTP nick‐end labeling stain), and microvessel density (by CD34 expression; angiogenesis). Results: Immunohistochemical investigations demonstrated immunolabeling of tumor cells with the primary antibodies, bovine anti‐iNOS and anti‐COX‐2 antibodies. The COX‐2 and iNOS positive rates were 41.7 and 66.7%, respectively. There was significant correlation between positive COX‐2 and positive iNOS expression (P = 0.043). The proliferation index (Ki‐67 labeling index) was higher in COX‐2 positive specimens compared to COX‐2 negative specimen (P = 0.015). The apoptotic index of positive iNOS expressions was significantly higher than negative expressions (P < 0.001). The expression of COX‐2 and iNOS proteins did not correlate with age, sex, serum bilirubin, CA‐19–9, location, size, American Joint Committee on Cancer stage, differentiation, distant metastasis, patient survival, or microvessel density. Conclusions: Although the pattern of positive expression was similar in both enzymes, the effect on tumor progression differed; iNOS expression may play a role in apoptosis of tumor cell, while COX‐2 expression may contribute to tumor proliferation. However, COX‐2 and iNOS expression is not related to prognosis in patients with pancreatic cancer. © 2002 Blackwell Publishing Asia Pty LtdKeywords
This publication has 35 references indexed in Scilit:
- Host cyclooxygenase-2 modulates carcinoma growthJCI Insight, 2000
- Tagungen und KongresseTransfusion Medicine and Hemotherapy, 1999
- Alteration of NF-κB p50 DNA Binding Kinetics by S-NitrosylationBiochemical and Biophysical Research Communications, 1997
- Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.JCI Insight, 1997
- Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ cultureBritish Journal of Pharmacology, 1997
- Cytokine and Low-Level Nitric Oxide Prestimulation Block p53 Accumulation and Apoptosis of Raw 264.7 MacrophagesBiochemical and Biophysical Research Communications, 1996
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells.JCI Insight, 1996
- Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human MacrophagesBiochemical and Biophysical Research Communications, 1995
- Nitric Oxide-stimulated Guanine Nucleotide Exchange on p21rasPublished by Elsevier BV ,1995